Here we screened the RASA1 and GDF2 genes for mutations in 93 patients suspected to have HHT, but tested negative for ENG, ACVRL1 and SMAD4, to determine whether their inclusion on an HHT testing panel would aid clinicians in making a diagnosis. The gene discussed is GDF2; the disease is hereditary hemorrhagic telangiectasia.